Companies / Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Nasdaq: MDGLCIK 1157601WEST CONSHOHOCKEN, PA
Financials · FY2025
Ownership
23.1M shares outstanding · as of Jul 27, 2026
Ownership
| Insiders | 12.24% | 2,828,759 |
| 10%+ / strategic | 7.39% | 1,707,522 |
| Institutions | 84.75% | 19,581,888 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 18
View all →| Insider | % of shares | Shares |
|---|---|---|
Baker Bros. Advisors LPDirector | 8.44% | 1,948,876 |
Taub RebeccaDirector | 1.96% | 452,667 |
Friedman Paul aDirector | 0.81% | 187,164 |
Sibold William JohnCEOPresident and CEO · Director | 0.70% | 161,829 |
Levy Richard SDirector | 0.10% | 22,469 |
Huntsman CaroleChief Commercial Officer | 0.05% | 12,692 |
Dier MardiEVP and CFO | 0.05% | 12,490 |
Kelley Shannon TGeneral Counsel | 0.05% | 12,138 |
Soergel DavidChief Medical Officer | 0.04% | 10,033 |
Daly James MDirector | 0.01% | 3,081 |
Institutional holders 398
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.16B | 8.63% | |
| $1.12B | 9.27% | |
| $1.05B | 7.83% | |
| $1.05B | 7.82% | |
| $1.05B | 8.74% | |
| $728.77M | 6.03% | |
| $644.75M | 5.20% | |
| $283.00M | 2.28% | |
| $268.69M | 2.00% | |
| $255.88M | 1.90% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $1.28M | -2K -1.24% | 194,222 0.84% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $1.27M | -2K -1.20% | 202,553 0.88% of shares | medium |
| Jan 20, 2026 | Taub Rebecca Director | Sell | Common Stock | $1.10M | -2K -0.49% | 453,351 1.96% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $1.06M | -2K -0.44% | 466,999 2.02% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $1.03M | -2K -0.96% | 205,769 0.89% of shares | medium |
| Jan 9, 2026 | Friedman Paul a Director | Sell | Common Stock | $822.1K | -2K -0.81% | 191,596 0.83% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $814.0K | -2K -0.33% | 469,564 2.03% of shares | medium |
| Jan 9, 2026 | Taub Rebecca Director | Sell | Common Stock | $781.9K | -1K -0.32% | 460,906 1.99% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| PAULSON & CO. INC. | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| PAULSON & CO. INC. | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MDGL | — | 558868105 |